| Reactive oxygen species regulation of autophagy in cancer: implications for cancer treatment L Li, G Ishdorj, SB Gibson Free Radical Biology and Medicine 53 (7), 1399-1410, 2012 | 184 | 2012 |
| Inactivation of the phospholipase B gene PLB5 in wild-type Candida albicans reduces cell-associated phospholipase A2 activity and attenuates virulence S Theiss, G Ishdorj, A Brenot, M Kretschmar, CY Lan, T Nichterlein, ... International Journal of Medical Microbiology 296 (6), 405-420, 2006 | 146 | 2006 |
| Inhibition of constitutive activation of STAT3 by curcurbitacin-I (JSI-124) sensitized human B-leukemia cells to apoptosis G Ishdorj, JB Johnston, SB Gibson Molecular cancer therapeutics 9 (12), 3302-3314, 2010 | 73 | 2010 |
| Death receptor-4 (DR4) expression is regulated by transcription factor NF-κB in response to etoposide treatment FJ Mendoza, G Ishdorj, X Hu, SB Gibson Apoptosis 13, 756-770, 2008 | 67 | 2008 |
| Oxygenation by COX-2 (cyclo-oxygenase-2) of 3-HETE (3-hydroxyeicosatetraenoic acid), a fungal mimetic of arachidonic acid, produces a cascade of novel bioactive 3 … R Ciccoli, S Sahi, S Singh, H Prakash, MP Zafiriou, G Ishdorj, JLF Kock, ... Biochemical Journal 390 (3), 737-747, 2005 | 50 | 2005 |
| Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells G Ishdorj, JB Johnston, SB Gibson BMC cancer 11, 1-12, 2011 | 44 | 2011 |
| The rat leukocyte-type 12-lipoxygenase exhibits an intrinsic hepoxilin A3 synthase activity S Nigam, S Patabhiraman, R Ciccoli, G Ishdorj, K Schwarz, B Petrucev, ... Journal of Biological Chemistry 279 (28), 29023-29030, 2004 | 43 | 2004 |
| Lysophosphatidic acid protects cancer cells from histone deacetylase (HDAC) inhibitor-induced apoptosis through activation of HDAC G Ishdorj, BA Graham, X Hu, J Chen, JB Johnston, X Fang, SB Gibson Journal of Biological Chemistry 283 (24), 16818-16829, 2008 | 42 | 2008 |
| Regulation of autophagy in hematological malignancies: role of reactive oxygen species G Ishdorj, L Li, SB Gibson Leukemia & lymphoma 53 (1), 26-33, 2012 | 37 | 2012 |
| IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia G Ishdorj, E Streu, P Lambert, HS Dhaliwal, SM Mahmud, SB Gibson, ... Blood advances 3 (14), 2188-2198, 2019 | 35 | 2019 |
| Epigenetic inactivation of TRAIL decoy receptors at 8p12‐21.3 commonly deleted region confers sensitivity to A po2L/trail‐C isplatin combination therapy in cervical cancer G Narayan, D Xie, G Ishdorj, L Scotto, M Mansukhani, B Pothuri, ... Genes, Chromosomes and Cancer 55 (2), 177-189, 2016 | 33 | 2016 |
| PCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis G Narayan, D Xie, AJ Freddy, G Ishdorj, C Do, P Satwani, H Liyanage, ... Genes, Chromosomes and Cancer 52 (11), 1030-1041, 2013 | 31 | 2013 |
| Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival G Ishdorj, S Beiggi, Z Nugent, E Streu, V Banerji, D Dhaliwal, SM Mahmud, ... Leukemia & lymphoma 60 (13), 3204-3213, 2019 | 29 | 2019 |
| Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells JY Yoon, G Ishdorj, BA Graham, JB Johnston, SB Gibson Apoptosis 19, 191-200, 2014 | 29 | 2014 |
| Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin B JY Yoon, D Szwajcer, G Ishdorj, P Benjaminson, W Xiao, R Kumar, ... Blood cancer journal 3 (10), e153-e153, 2013 | 26 | 2013 |
| Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced … W Xiao, G Ishdorj, J Sun, JB Johnston, SB Gibson Leukemia & lymphoma 52 (7), 1290-1301, 2011 | 21 | 2011 |
| A novel spliced variant of the TIN2 shelterin is present in chronic lymphocytic leukemia G Ishdorj, SEF Kost, S Beiggi, Y Zang, SB Gibson, JB Johnston Leukemia Research 59, 66-74, 2017 | 6 | 2017 |
| Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines G Ishdorj, Z Nugent, M Squires, S Kost, V Banerji, L Davidson, CS Katyal, ... Leukemia Research 109, 106628, 2021 | 4 | 2021 |
| Effect of Valproic Acid (VPA) on Fludarabine Activity In Chronic Lymphocytic Leukemia (CLL) Patients JY Yoon, D Szwajcer, G Ishdorj, P Benjaminson, SB Gibson, JB Johnston Blood 116 (21), 4626, 2010 | 1 | 2010 |
| A unique spliced isoform of TIN2 is expressed in chronic lymphocytic leukemia G Ishdorj, S Gibson, S Kost, J Johnston, S Beiggi LEUKEMIA & LYMPHOMA 58, 216-217, 2017 | | 2017 |